184 related articles for article (PubMed ID: 28598536)
1. Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
Creutzig U; Dworzak MN; Zimmermann M; Reinhardt D; Sramkova L; Bourquin JP; Hasle H; Abrahamsson J; Kaspers G; van den Heuvel MM; Reedijk AMJ; De Moerloose B; Locatelli F; Masetti R
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598536
[TBL] [Abstract][Full Text] [Related]
2. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
3. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
4. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
[TBL] [Abstract][Full Text] [Related]
5. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
Aldoss I; Al Malki MM; Stiller T; Cao T; Sanchez JF; Palmer J; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Mar; 22(3):575-8. PubMed ID: 26493564
[TBL] [Abstract][Full Text] [Related]
6. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
7. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
8. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
[TBL] [Abstract][Full Text] [Related]
9. Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement.
Mayadev JS; Douglas JG; Storer BE; Appelbaum FR; Storb R
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):193-8. PubMed ID: 20584584
[TBL] [Abstract][Full Text] [Related]
10. Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.
Zheng C; Liu X; Zhu W; Cai X; Wu J; Sun Z
Hematology; 2014 Jun; 19(4):208-12. PubMed ID: 24074528
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Chen Q; Zhu XL; Zhao X; Liu X; Fu HX; Zhang YY; Chen YH; Mo XD; Han W; Chen H; Yan CH; Wang Y; Chang YJ; Xu LP; Huang XJ; Zhang XH
Ann Hematol; 2021 Feb; 100(2):505-516. PubMed ID: 33389025
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
[TBL] [Abstract][Full Text] [Related]
13. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
14. Very late isolated CNS relapse of acute myeloid leukemia.
Molina B; Lassaletta A; Gonzalez-Vicent M; Andión M; Diaz MA; Madero L
J Pediatr Hematol Oncol; 2013 Mar; 35(2):e57-9. PubMed ID: 23412589
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
16. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M
J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508
[TBL] [Abstract][Full Text] [Related]
18. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
[TBL] [Abstract][Full Text] [Related]
19. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
